As of 2025-03-19, the Relative Valuation of Forte Biosciences Inc (FBRX) is (145.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.50 USD, the upside of Forte Biosciences Inc based on Relative Valuation is -2746.5%.
The range of the Relative Valuation is (115.48) - (166.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 36.8x | 29.2x |
| Forward P/E multiples | 19.3x - 31.1x | 25.2x |
| Fair Price | (115.48) - (166.32) | (145.56) |
| Upside | -2199.7% - -3124.0% | -2746.5% |
| Date | P/E |
| 2025-02-28 | -1.70 |
| 2025-02-27 | -1.74 |
| 2025-02-26 | -1.74 |
| 2025-02-25 | -1.75 |
| 2025-02-24 | -1.80 |
| 2025-02-21 | -2.05 |
| 2025-02-20 | -2.00 |
| 2025-02-19 | -1.87 |
| 2025-02-18 | -2.10 |
| 2025-02-14 | -2.24 |
| 2025-02-13 | -2.08 |
| 2025-02-12 | -2.06 |
| 2025-02-11 | -2.08 |
| 2025-02-10 | -2.06 |
| 2025-02-07 | -2.23 |
| 2025-02-06 | -2.43 |
| 2025-02-05 | -2.80 |
| 2025-02-04 | -2.80 |
| 2025-02-03 | -2.80 |
| 2025-01-31 | -2.97 |
| 2025-01-30 | -2.98 |
| 2025-01-29 | -2.74 |
| 2025-01-28 | -2.78 |
| 2025-01-27 | -2.85 |
| 2025-01-24 | -2.83 |
| 2025-01-23 | -2.97 |
| 2025-01-22 | -2.99 |
| 2025-01-21 | -2.75 |
| 2025-01-17 | -2.92 |
| 2025-01-16 | -2.95 |
| 2025-01-15 | -3.08 |
| 2025-01-14 | -2.73 |
| 2025-01-13 | -2.99 |
| 2025-01-10 | -3.32 |
| 2025-01-08 | -3.63 |
| 2025-01-07 | -3.88 |
| 2025-01-06 | -4.22 |
| 2025-01-03 | -4.58 |
| 2025-01-02 | -4.72 |
| 2024-12-31 | -4.24 |
| 2024-12-30 | -3.95 |
| 2024-12-27 | -4.28 |
| 2024-12-26 | -4.02 |
| 2024-12-24 | -3.68 |
| 2024-12-23 | -3.55 |
| 2024-12-20 | -3.61 |
| 2024-12-19 | -3.49 |
| 2024-12-18 | -3.50 |
| 2024-12-17 | -3.67 |
| 2024-12-16 | -3.54 |